Aldosterone and Vascular Mineralocorticoid Receptors in Murine Endotoxic and Human Septic Shock*

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Critical Care Medicine

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/CCM.0000000000002462PMID 28445239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

  2016cited by this paper
• Role of smooth muscle cell mineralocorticoid receptor in vascular tone

  2015cited by this paper
• Neutrophil Gelatinase–Associated Lipocalin, a Novel Mineralocorticoid Biotarget, Mediates Vascular Profibrotic Effects of Mineralocorticoids

  2015cited by this paper
• Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology

  2015cited by this paper
• Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease.

  2014cited by this paper
• Smooth Muscle Cell Mineralocorticoid Receptors Are Mandatory for Aldosterone–Salt to Induce Vascular Stiffness

  2014cited by this paper
• Fludrocortisone and Hydrocortisone, Alone or in Combination, on In Vivo Hemodynamics and In Vitro Vascular Reactivity in Normal and Endotoxemic Rats: A Randomized Factorial Design Study

  2014cited by this paper
• Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

  2013cited by this paper
• Current Concepts in Orthostatic Hypotension Management

  2013cited by this paper
• Severe sepsis and septic shock.

  2013cited by this paper
• The Aldosterone-Mineralocorticoid Receptor Pathway Exerts Anti-Inflammatory Effects in Endotoxin-Induced Uveitis

  2012cited by this paper
• Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock

  2012cited by this paper
• Direct Regulation of Blood Pressure by Smooth Muscle Cell Mineralocorticoid Receptors

  2012cited by this paper
• Specific regulatory motifs predict glucocorticoid responsiveness of hippocampal gene expression.

  2011cited by this paper
• Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children

  2011cited by this paper
• The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure

  2010cited by this paper
• Regulation of mineralocorticoid receptor expression during neuronal differentiation of murine embryonic stem cells.

  2010cited by this paper
• Involvement of central angiotensin II type 1 receptors in LPS-induced systemic vasopressin release and blood pressure regulation in rats.

  2009cited by this paper
• INHIBITION OF NF-&kgr;B ACTIVITY PREVENTS DOWNREGULATION OF &agr;1-ADRENERGIC RECEPTORS AND CIRCULATORY FAILURE DURING CLP-INDUCED SEPSIS

  2009cited by this paper
• Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.

  2009cited by this paper
• Role of nuclear factor-&kgr;B-dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture-induced circulatory failure*

  2008cited by this paper
• Hydrocortisone therapy for patients with septic shock.

  2008cited by this paper
• Regulation of renal glucose transporters during severe inflammation.

  2007cited by this paper
• A Nuclear Receptor Atlas: macrophage activation.

  2005cited by this paper
• Cytokines down-regulate &agr;1-adrenergic receptor expression during endotoxemia

  2003cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

  2002cited by this paper
• Neuroendocrine mediators up-regulate α1b- and α1d-adrenergic receptor subtypes in human monocytes

  1999cited by this paper
• Neuroendocrine mediators up-regulate alpha1b- and alpha1d-adrenergic receptor subtypes in human monocytes.

  1999cited by this paper
• Multiple potential regulatory elements in the 5' flanking region of the human alpha 1a-adrenergic receptor.

  1998cited by this paper
• Multiple Potential Regulatory Elements in the 5′ Flanking Region of the Human al,-Adrenergic Receptor:Short Communication

  1998cited by this paper
• The Rat α1B Adrenergic Receptor Gene Middle Promoter Contains Multiple Binding Sites for Sequence-specific Proteins Including a Novel Ubiquitous Transcription Factor (*)

  1995cited by this paper
• Establishment of Lipopolysaccharide-dependent Nuclear Factor κB Activation in a Cell-free System (*)

  1995cited by this paper
• SEPSIS DECREASES PHENYLEPHRINE− AND KCl‐INDUCED AORTIC RING CONTRACTION AND DECREASES THE FREQUENCY OF OSCILLATIONS IN ACTIVE WALL TENSION

  1994cited by this paper
• Pathogenetic mechanisms of septic shock.

  1993cited by this paper
• Effects of aldosterone and dexamethasone on blood chemical mediators in endotoxin shock

  1979cited by this paper
• Mineralocorticoid-induced hypertension in patients with orthostatic hypotension.

  1979cited by this paper
• Septic Shock

  1970cited by this paper

• Hydrocortisone combined with fludrocortisone for treatment of adults with septic shock: an updated meta-analysis and systematic review.

  2026cites this paper
• Corticosteroids in sepsis

  2025cites this paper
• The Glucocorticoid System: A Multifaceted Regulator of Mitochondrial Function, Endothelial Homeostasis, and Intestinal Barrier Integrity

  2025cites this paper
• Corticosteroids in sepsis: certainties and shadows

  2025cites this paper
• Mortality of severe pneumonia treated with methylprednisolone versus hydrocortisone: a propensity-matched analysis

  2025cites this paper
• Esteroides, sepsis y shock séptico: de la plausibilidad biológica a la evidencia actual. Revisión narrativa

  2025cites this paper
• Fludrocortisone dose–response relationship in septic shock: a randomised phase II trial

  2024cites this paper
• Fat Embolism Syndrome Treated with Methylprednisolone

  2024cites this paper
• Uncomplicated circulatory shock: a narrative review

  2024cites this paper
• Effect of hydrocortisone-fludrocortisone combination on mortality in septic shock: a systematic review and meta-analysis

  2024cites this paper
• The effect of hydrocortisone versus hydrocortisone plus fludrocortisone on duration of shock: A propensity score-weighted analysis

  2024cites this paper
• The Evolving Understanding of Glucocorticoid Treatment in Septic Shock.

  2023cites this paper
• The Mineralocorticoid Receptor in the Vasculature: Friend or Foe?

  2023cites this paper
• Myeloid Mineralocorticoid Receptor Transcriptionally Regulates P-Selectin Glycoprotein Ligand-1 and Promotes Monocyte Trafficking and Atherosclerosis

  2021cites this paper
• Examination of the association of steroids with fluid accumulation in critically ill patients, considering the possibility of biases

  2021cites this paper
• Mineralocorticoid pathway in retinal health and diseases

  2021cites this paper
• G Protein-Coupled Estrogen Receptor 1 (GPER1) Mediates Aldosterone-Induced Endothelial Inflammation in a Mineralocorticoid Receptor-Independent Manner

  2021cites this paper
• Hydrocortisone with fludrocortisone for septic shock: a systematic review and meta‐analysis

  2020cites this paper
• Corticosteroids for Septic Shock: Another Chapter in the Saga

  2020cites this paper
• General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections

  2020cites this paper
• Hydrocortisone with Fludrocortisone for Adult Patients with Septic Shock: A Systematic Review and Meta-Analysis

  2020cites this paper
• Vasopressin in Vasodilatory Shock.

  2019cites this paper
• Adjunctive Corticosteroid Treatment in Septic Shock.

  2019cites this paper
• Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock

  2019cites this paper
• Vascular mineralocorticoid receptor activation and disease.

  2019cites this paper
• Why the Adjunctive Corticosteroid Treatment in Critically Ill Patients With Septic Shock (ADRENAL) Trial Did Not Show a Difference in Mortality?

  2019cites this paper
• Combination of low-dose glucocorticosteroids and mineralocorticoids as adjunct therapy for adult patients with septic shock: A systematic review and meta-analysis of randomized trials and observational studies

  2019cites this paper
• Steroids and Sepsis: the Debate Continues

  2019cites this paper
• Hydrocortisone in Vasodilatory Shock.

  2019cites this paper
• Hydrocortisone plus Fludrocortisone for Adults with Septic Shock

  2018cites this paper
• Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms

  2018cites this paper
• ADRENAL trial versus APROCCHSS trial: to steroid or not to steroid?

  2018cites this paper
• Recent Updates in the Pharmacological Management of Sepsis and Septic Shock: A Systematic Review Focused on Fluid Resuscitation, Vasopressors, and Corticosteroids

  2018cites this paper
• Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock ‐ a meta‐analysis of randomized controlled trials and trial sequential analysis

  2018cites this paper
• Effect of Low-Dose Hydrocortisone Therapy in Adult Patients With Septic Shock: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials

  2018cites this paper
• Immune Effects of Corticosteroids in Sepsis

  2018influential citation
• The Deletion of Endothelial Sodium Channel α (αENaC) Impairs Endothelium-Dependent Vasodilation and Endothelial Barrier Integrity in Endotoxemia in Vivo

  2018cites this paper
• Steroids Redux: Targeting the Mineralocorticoid Axis in Sepsis.

  2017cites this paper